Back to top
more

Tempus AI, Inc. (TEM)

(Delayed Data from NSDQ)

$66.17 USD

66.17
11,900,400

-6.52 (-8.97%)

Updated Aug 24, 2026 04:00 PM ET

After-Market: $65.69 -0.48 (-0.73%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (77 out of 247)

Industry: Medical Info Systems

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Urmimala Biswas headshot

Tempus AI Near $75 Target? Valuation, Upside and Risks

by Urmimala Biswas

Tempus AI's rally meets a $75 target. Here's how valuation, catalysts, risks, and key numbers set up the risk-reward into 2026.

Sridatri Sarkar headshot

Tempus AI's Strategic Push to Expand Beyond Oncology

by Sridatri Sarkar

TEM extends its AI tools beyond oncology, adding FDA-cleared cardiac and ECG software plus key acquisitions to deepen its diagnostic reach.

Sridatri Sarkar headshot

Is TEM Stock a Buy, Hold, or Sell During Its Pivotal Transition?

by Sridatri Sarkar

Tempus AI's shift toward scalable revenues, high-margin data services and broader AI capabilities defines a pivotal moment for TEM investors.

Urmimala Biswas headshot

Is Tempus AI Stock a Buy Now or a Hold After a Big 2025 Run?

by Urmimala Biswas

Tempus AI rallies in 2025, but a Hold rank and mixed style scores argue for patience until pricing, FDA, and MRD milestones firm up.

Urmimala Biswas headshot

Tempus AI: Data Flywheel and MRD Expansion Reshape the Outlook

by Urmimala Biswas

Tempus AI's data engine, MRD buildout and ADLT milestones set the stage for faster growth while profitability metrics turn the corner.

Urmimala Biswas headshot

Tempus AI: Revenue Mix and 2026 Growth Outlook Explained

by Urmimala Biswas

Tempus AI's balanced genomics and data engine is scaling fast as profitability metrics improve and 2026 revenue targets approach the billion-plus mark.

Sridatri Sarkar headshot

Tempus AI Boosts Its Clinical AI Capabilities Through Strategic Moves

by Sridatri Sarkar

TEM expands its clinical AI reach through regulatory wins, a new oncology partnership and a major digital-pathology acquisition.

Zacks Equity Research

Why Is Tempus (TEM) Down 8.9% Since Last Earnings Report?

by Zacks Equity Research

Tempus (TEM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Debanjana Dey headshot

Hims & Hers Expands Care Scope as Digital Health Platforms Evolve

by Debanjana Dey

HIMS expands into low testosterone and menopause care, with plans for longevity and global growth in 2026.

Sridatri Sarkar headshot

Tempus AI's Data Business Is Expanding and Adding to Revenues: Here's How

by Sridatri Sarkar

TEM's surging Insights revenues, new contracts and expanded AI capabilities highlight its shift toward scalable data-driven growth.